News about Global Pharma

Sun Pharma Presents New Clinical Efficacy and Safety Data in Dermatology at EADV Congress

The company will also share results in two additional posters for deuruxolitinib, which showed clinically meaningful improvement in anxiety and depression among patients taking deuruxolitinib to treat their severe AA (P2022) as well as dose optimization for deuruxolitinib at 8 mg (P2081).

Global Pharma | 27/09/2024 | By Aishwarya |  966

Biocon Join Hands with Tabuk Pharma to Commercialize its GLP -1 Products in Middle East

The agreement also provides for a provision to expand to other GLP products, as well as the option of a tech transfer that will enable localized manufacturing at a later stage.

Global Pharma | 27/09/2024 | By Aishwarya |  945

UCB Gets FDA Approval for BIMZELX for Treatment of Psoriatic Arthritis

BIMZELX is the first approved treatment for these three indications that is designed to selectively inhibit two key cytokines driving inflammatory processes – interleukin 17A (IL-17A) and interleukin 17F (IL-17F).

Global Pharma | 24/09/2024 | By Aishwarya |  974

Antengene Receives Approval for XPOVIO for Commercialisation in Thailand

This successful approval for XPOVIO in Thailand will introduce novel therapies to the clinical management of patients with MM in Thailand, benefiting many patients and their families in the country.

Global Pharma | 24/09/2024 | By Aishwarya |  653

Agilent Announces Acquisition of BIOVECTRA

With the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing.

Global Pharma | 24/09/2024 | By Aishwarya |  583

Vicebio Raises USD 100 Million in Series B Financing Round

Vicebio is developing next-generation vaccines for respiratory viruses utilising its proprietary Molecular Clamp technology, discovered at The University of Queensland.

Global Pharma | 23/09/2024 | By Aishwarya |  527

Astellas Gets EU Approval for VYLOY in Combination with Chemotherapy

Astellas Pharma Inc. has announced that the European Commission (EC) has approved VYLOY (zolbetuximab) in combination with fluoropyrimidine- and platinum-containing chemotherapy.

Global Pharma | 23/09/2024 | By Aishwarya |  726

Alkem Foundation Organises Walkathons to Raise Awareness about Alzheimer's Disease

Alkem Foundation collaborated with non-profit organization, HelpAge India for these walkathons, which were conducted at Girgaon Chowpatty in Mumbai, Deer Park in New Delhi, Chetla Central Park in Kolkata, Anna Nagar Tower Park in Chennai and National College Ground in Bengaluru.

Global Pharma | 21/09/2024 | By Aishwarya |  707

FDA Approves Nasal Spray Influenza Vaccine for Caregiver Administration

FluMist is approved for preventing influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age.

Global Pharma | 21/09/2024 | By Aishwarya |  869

Suven Pharmaceuticals Announces Appointment of Vivek Sharma as Executive Chairman

Vivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions and as Chairman & CEO of Adare Pharma Solutions, a technology CDMO business (2020-22).

Global Pharma | 21/09/2024 | By Aishwarya |  762